Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 45, Issue 5, May 2020, Pages 283-363
 
IN MEMORIAM
 
  
 In memoriam: Dr. J.R. Prous.
Drugs Fut 2020, 45(5): 283
Full Text: PDF 
 
  
 
MONOGRAPHS
 
  
 Atogepant.
Calcitonin gene-related peptide (CGRP) receptor antagonist, Preventive treatment of migraine.
Martelletti, P., Cipolla, F., Capi, M., Curto, M., Lionetto, L.
Drugs Fut 2020, 45(5): 285
Summary | Full Text: PDF 
 
  
  
 Narsoplimab.
Anti-mannan-binding lectin-associated serine protease 2 (MASP-2) antibody, Treatment of transplant-associated thrombotic microangiopathies, Treatment of IgA nephropathy.
Gras, J.
Drugs Fut 2020, 45(5): 299
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLE
 
  
 Rationale of targeting protein cereblon as a potential strategy for cancer treatment.
Fuchs, O., Bokorova, R.
Drugs Fut 2020, 45(5): 305
Summary | Full Text: PDF 
 
  
 
FILLING THE GAPS IN DRUG THERAPY
 
  
 Filling the gaps in Richter syndrome: options in the pipeline.
Shah, A., Barrientos, J.C.
Drugs Fut 2020, 45(5): 319
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Torramade, E., Molas, G., Presa, A.
Drugs Fut 2020, 45(5): 333
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 Conference on Retroviruses and Opportunistic Infections (CROI) 2020. March 8-11, 2020.
Croasdell, G., Watt, J., Cole, P., Bofill, X.
Drugs Fut 2020, 45(5): 349
Summary | Full Text: PDF 
 
  
  
 CHI's 5th Annual Immuno-Oncology Summit Europe. London, UK – March 9-12, 2020.
Jago, C.
Drugs Fut 2020, 45(5): 359
Summary | Full Text: PDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy